← SynDRA
HTS-466284
SynDRA canonical compound SYN1968677 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | TGFBR1 |
| Mechanism of action | p38 MAPK inhibitor | TGF beta receptor inhibitor |
All known targets
Mechanisms of action (all sources)
- MAPK14 INHIBITOR
- TGF beta receptor inhibitor
- TGFBR1 INHIBITOR
Cross-references
Synonyms
- 4-(3-Pyridin-2-YL-1H-pyrazol-4-YL)quinoline
- LY 364947
- LY364947
- 4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)quinoline
- TbetaR-I Inhibitor
- ALK5 Inhibitor I
- TGF-beta RI Kinase Inhibitor
- 4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]quinoline
- CHEMBL261454
- Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor
- 4-(3-pyridin-2-yl)(1h)-pyrazol-4-yl quinoline
- 4-[3-(2-Pyridinyl)-1H-pyrazol-4-yl]quinoline
- [3-(Pyridin-2-yl)-4-(4-quinonyl)]-1H-pyrazole
- 4-(3-PYRIDIN-2-YL-1H-PYRAZOL-4-YL)QUINOLINE
- 4-(5-pyridin-2-yl-1H-pyrazol-4-yl)quinoline
- HTS466284
- 4-[5-(pyridin-2-yl)-1H-pyrazol-4-yl]quinoline
- SR-01000385325
- MFCD00800758
- Quinoline, 4-[3-(2-pyridinyl)-1H-pyrazol-4-yl]-
- 1py5
- Peakdale1_000394
- 4-[3-(2-pyridinyl)-1H-pyrazol-4-yl]-quinoline
- SCHEMBL373665
- GTPL6050
- Isoxazol-5-ylmethyl-methylamine
- SCHEMBL21233972
- BDBM21492
- CHEBI:91198
- CHEBI:92118
- HMS519B20
- DTXSID90332266
- EX-A133
- HMS2043N21
- HMS3229M09
- HMS3269P09
- HMS3648O10
- HMS3677D10
- HMS3742E17
Look up HTS-466284 in the interactive SynDRA portal →